given that 1985, the drug continues to be detailed for a Schedule I drug within the US, making it effectively unlawful for all uses. nonetheless, clinical trials are already authorized and carried out lately, and in 2017, the FDA granted MDMA “breakthrough therapy” position. It’s imagined the doctors could be prescribing the drug as early as